Dr. Keun Hyung Park, Sunjin Clinical Research Center (SCRC), Sunjin BeautyScience Co., Ltd., South Korea
Dr. Keun Hyung Park is an accomplished expert in genetic engineering and immunology, with a PhD from Kyung Hee University (2014). He currently serves as the Head of Sunjin Clinical Research Center and is an advisory committee member at Korea Bio Research Center. Dr. Park has published extensively on skin science, wound healing, and inflammation, contributing to top journals like J Immunol and Skin Research & Technology. He is also a recognized voice in the cosmetics industry through his insightful columns on K-beauty trends. 🧬💼💡 His expertise spans molecular biology, clinical research, and dermatological studies.
Publication profile
Scopus
Education 🎓
Dr. Keun Hyung Park holds advanced degrees in Genetic Engineering with a focus on Immunology from Kyung Hee University. He earned his Master’s degree in 2008, gaining a strong foundation in molecular biology and immunology. Continuing his academic journey, he completed his PhD in 2014, further specializing in immunology-related genetic engineering. His extensive education has equipped him with the expertise to contribute significantly to the fields of molecular biology, clinical research, and dermatology, positioning him as a leader in both academic and industry settings. 🧬📚
Professional Experience 🧑🔬
Dr. Keun Hyung Park is currently the Head of SUNJIN Clinical Research Center, where he serves as Director and Principal Investigator (PI) since 2024. He is also a member of the expert committee for Cosinkorea and an advisory committee member of the Korea Bio Research Center. Previously, he was a lecturer in molecular biology at Kyung Hee University (2012-2013) and led the safety clinical team at IEC Korea (2014-2020). He held key roles in skin clinical consulting, including at THE K BEAUTY SCIENCE and OATC Skin Clinical Trial Center. 🧫🧴
Research Focus
Dr. Keun Hyung Park’s research primarily focuses on immunology and inflammation, particularly the molecular mechanisms underlying inflammatory responses and their modulation. His work explores the role of natural compounds in attenuating inflammation and promoting angiogenesis. Dr. Park investigates signaling pathways such as MAPK and NF-κB, contributing to our understanding of how these pathways influence immune cell behavior and tissue healing. Additionally, he examines the effects of various natural extracts on cellular processes, emphasizing their potential therapeutic applications in treating inflammatory diseases and enhancing wound healing. His research has significant implications for developing innovative treatments in biomedicine. 🧬🌿💉
Publication Top Notes
- Cynandione A attenuates lipopolysaccharide-induced production of inflammatory mediators via MAPK inhibition and NF-κB inactivation in RAW264.7 macrophages and protects mice against endotoxin shock (30 citations) – 2015 🐭
- Jaceosidin, a natural flavone, promotes angiogenesis via activation of VEGFR2/FAK/PI3K/AKT/NF-κB signaling pathways in endothelial cells (28 citations) – 2014 🌱
- The stimulatory effects of Stewartia koreana extract on the proliferation and migration of fibroblasts and the wound healing activity of the extract in mice (20 citations) – 2014 🩹
- Enhancement of CCL15 expression and monocyte adhesion to endothelial cells (ECs) after hypoxia/reoxygenation and induction of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs (33 citations) – 2013 🔬
- Human lactoferrin suppresses TNF-α-induced intercellular adhesion molecule-1 expression via competition with NF-κB in endothelial cells (31 citations) – 2012 🧬